Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Child: Care, Health and Development|April 30, 2021
Improving engagement with services to prevent Sudden Unexpected Death in Infancy (SUDI) in families with children at risk of significant harm: A systematic review of evidenceJoanna Garstang, Debbie Watson, Anna Pease, et al.
Frontiers in Pediatrics|January 20, 2022
Interventions to Improve Safer Sleep Practices in Families With Children Considered to Be at Increased Risk for Sudden Unexpected Death in Infancy: A Systematic ReviewCatherine Ellis, Anna Pease, Joanna Garstang, et al.
Lancet (London, England)|September 12, 2014
Understanding why children die in high-income countriesPeter Sidebotham, James Fraser, Teresa Covington, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 25, 2024
Myelofibrosis symptom assessment form total symptom score version 4.0: measurement properties from the MOMENTUM phase 3 studyChristina Daskalopoulou, Boris Gorsh, Gerasimos Dumi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2013
Quantitative ER and PgR assessment as predictors of benefit from lapatinib in postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancerRichard S Finn, Michael F Press, Judy Dering, et al.
BMJ Paediatrics Open|March 23, 2021
Decision-making for the infant sleep environment among families with children considered to be at risk of sudden unexpected death in infancy: a systematic review and qualitative metasynthesisAnna Pease, Joanna J Garstang, Catherine Ellis, et al.
Breast Cancer Research : BCR|July 25, 2014
Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel aloneBinghe Xu, Zhongzhen Guan, Zhenzhou Shen, et al.
Clinical and Translational Science|August 27, 2024
Momelotinib: Mechanism of action, clinical, and translational scienceGeorgios Vlasakakis, Michael T McCabe, Yu Liu Ho, et al.
Future Oncology (London, England)|June 6, 2025
Indirect treatment comparisons of momelotinib vs pacritinib safety and anemia outcomes in patients with myelofibrosisLucia Masarova, Srdan Verstovsek, Francesca Palandri, et al.
Ejhaem|June 19, 2025
Time Without Transfusion Reliance (TWiTR): Integrating Survival Quality Into Myelofibrosis Treatment Strategies Based on the Phase 3 SIMPLIFY-1, SIMPLIFY-2, and MOMENTUM TrialsRuben A Mesa, Moshe Talpaz, Flora Mazerolle, et al.
Pageof 5